RE: Rns9 Jun 2026 17:30
Hello Scot.
Thank you for taking the time to post such a detailed response. I think we agree on more than we disagree.
On the timing point, I agree that if TW2 is to be drilled during the 26/27 winter season, then a JV would likely need to be substantially progressed before 31 December. My interpretation of the RSU condition is not that management expects to sign a deal at year-end, but rather that the Board wanted a clear and measurable deadline for the award.
I also agree that not all farm-outs are equal. Securing a partner is one thing; securing a partner on terms that properly reflect the value of the assets is another. Shareholders should judge any transaction on its economics and long-term value creation, not simply on whether a deal is announced.
On remuneration, I understand the concerns around the scale of the awards and the absence of more explicit performance hurdles. I would certainly welcome meaningful open-market purchases by management. I think most shareholders would view that positively, as it demonstrates direct alignment and personal conviction.
Where I perhaps differ is on the purpose of these awards. My reading is that the Board is trying to retain a team through what could be a transition from appraisal into development. If a JV is secured, Pantheon's challenges do not disappear. In many respects they become greater. The company would potentially move into partner management, development planning, drilling execution, commercial negotiations and ultimately field development. That is a very different task from where the company sits today.
For me, the most important point remains that the Board has specifically linked part of the CEO's long-term incentive to securing a JV partner. That does not guarantee success, nor does it guarantee attractive terms, but it does suggest that the Board continues to view a strategic transaction as both achievable and central to unlocking value.
I also appreciate your comments regarding Spencer's CFD purchase. We may have different views on remuneration, but I think it is important that the forum remains focused on facts. The RNS clearly shows that his economic exposure increased, and I am pleased we are in agreement that the suggestion he was shorting the company is simply incorrect.
Ultimately, I suspect we both want the same thing. A transaction that properly reflects the quality of the assets and creates meaningful value for shareholders. The remuneration debate is interesting, but the real test will be whether management can deliver that outcome.
Thanks again for the thoughtful discussion.
X